C2-C7 alkyl boronic acids as antimicrobial antiviral therapeutic compounds

USPTO issued patent grant US12589103B2 to Cornell University for C2-C7 alkyl boronic acids as antimicrobial and antiviral therapeutic compounds. The patent covers methods of using these chemical compounds to treat bacterial and viral infections by reducing growth and virulence. CPC classifications include A61K 31/69 (boron compounds), A61P 31/14 (antivirals), and A61P 31/04 (antibacterials).

This is a routine patent grant notification with no compliance requirements for third parties. Organizations developing antimicrobial or antiviral therapeutics should review this patent to assess potential freedom-to-operate implications. No action is required unless the organization plans to develop or commercialize boron-based antimicrobial compounds overlapping with the 28 patented claims.